Form 8-K - Current report:
SEC Accession No. 0001558370-24-000128
Filing Date
2024-01-08
Accepted
2024-01-08 08:30:12
Documents
15
Period of Report
2024-01-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hrmy-20240108x8k.htm   iXBRL 8-K 44557
2 EX-99.1 hrmy-20240108xex99d1.htm EX-99.1 42338
3 GRAPHIC hrmy-20240108x8k001.jpg GRAPHIC 1167
4 GRAPHIC hrmy-20240108xex99d1001.jpg GRAPHIC 9783
  Complete submission text file 0001558370-24-000128.txt   234551

Data Files

Seq Description Document Type Size
5 EX-101.SCH hrmy-20240108.xsd EX-101.SCH 3160
6 EX-101.LAB hrmy-20240108_lab.xml EX-101.LAB 15925
7 EX-101.PRE hrmy-20240108_pre.xml EX-101.PRE 10078
9 EXTRACTED XBRL INSTANCE DOCUMENT hrmy-20240108x8k_htm.xml XML 4831
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filer) CIK: 0001802665 (see all company filings)

EIN.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39450 | Film No.: 24518485
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)